Sickle Cell Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Blood Transfusion, Bone Marrow Transplant), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Report Scope and Objectives
                  1.1 Market Segmentation and Scope
                      1.1.1 Segment Definitions
                          1.1.1.1 Treatment segment
                          1.1.1.2 End-use segment
                  1.2 Regional Scope
                  1.3 Estimates and Forecast Timeline
                  1.4 Objectives
                      1.4.1 Objective - 1
                      1.4.2 Objective - 2
                      1.4.3 Objective - 3
                  1.5 Research Methodology
                  1.6 Information Procurement
                      1.6.1 Purchased Database
                      1.6.2 GVR’s Internal Database
                      1.6.3 Secondary Sources
                      1.6.4 Primary research
                  1.7 Information or Data Analysis
                      1.7.1 Data Analysis Models
                  1.8 Market Formulation & Validation
                  1.9 Model Details
                      1.9.1 Commodity Flow Analysis
                  1.10 List of Secondary Sources
                  1.11 List of Abbreviations
Chapter 2 Executive Summary
                  2.1 Market Outlook
                  2.2 Segment Outlook
                      2.2.1 Treatment
                      2.2.2 End-use
                      2.2.3 Region
                  2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                  3.2 Sickle cell disease treatment Market Dynamics
                      3.2.1 Market Driver Analysis
                          3.2.1.1 Increasing prevalence of disease
                          3.2.1.2 Awareness programs and services
                          3.2.1.3 Presence of reimbursement policies
                      3.2.2 Market Restraint Analysis
                          3.2.2.1 Adverse effects and risks related to the treatment procedure
                  3.3 Sickle cell disease treatment Market: Business Environment Analysis Tools
                      3.3.1 PORTER’S Five Forces Analysis 
                          3.3.1.1 Threat of new entrants
                          3.3.1.2 Bargaining power of suppliers
                          3.3.1.3 Bargaining power of buyers
                          3.3.1.4 Competitive rivalry
                          3.3.1.5 Threat of substitutes
                      3.3.2 PESTEL Analysis
                          3.3.2.1 Political & Legal
                          3.3.2.2 Economic & Social
                          3.3.2.3 Technological
                  3.4 Penetration & Growth Prospect Mapping
                  3.5 Impact of COVID-19 on the sickle cell disease treatment market
Chapter 4 Sickle Cell Disease Treatment Market: Treatment Analysis
                  4.1 Sickle Cell Disease Treatment Treatment Market Share Analysis, 2018 & 2030
                  4.2 Sickle Cell Disease Treatment Treatment Market: Segment Dashboard:
                  4.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Treatment Segment
                      4.3.1 Bone Marrow Transplant
                          4.3.1.1 Bone marrow transplant market, 2018 - 2030 (USD Million)
                      4.3.2 Blood Transfusion
                          4.3.2.1 Blood transfusion market, 2018 - 2030 (USD Million)
                      4.3.3 Pharmacotherapy
                          4.3.3.1 Pharmacotherapy market, 2018 - 2030 (USD Million)
Chapter 5 Sickle Cell Disease Treatment Market: End-use Analysis
                  5.1 Sickle Cell Disease Treatment End-use Mode Market Share Analysis, 2018 & 2030
                  5.2 Sickle Cell Disease Treatment End-use Mode Market: Segment Dashboard
                  5.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the End-use Mode Segment
                      5.3.1 Hospitals
                          5.3.1.1 Hospitals market, 2018 - 2030 (USD Million)
                      5.3.2 Specialty Clinics
                          5.3.2.1 Specialty Clinics market, 2018 - 2030 (USD Million)
                      5.3.3 Others
                          5.3.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 6 Sickle Cell Disease Treatment Market: Regional Analysis
                      6.1. Sickle Cell Disease Market Share By Region, 2023 & 2030
                      6.2. North America
                          6.2.1. SWOT Analysis
                          6.2.2. North America Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.2.3. U.S.
                              6.2.3.1. Key Country Dynamics
                              6.2.3.2. Target Disease Prevalence
                              6.2.3.3. Competitive Scenario
                              6.2.3.4. Regulatory Framework
                              6.2.3.5. U.S. Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.2.4. Canada
                              6.2.4.1. Key Country Dynamics
                              6.2.4.2. Target Disease Prevalence
                              6.2.4.3. Competitive Scenario
                              6.2.4.4. Regulatory Framework
                              6.2.4.5. Canada Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                      6.3. Europe
                          6.3.1. SWOT Analysis
                          6.3.2. Europe Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.3. UK
                              6.3.3.1. Key Country Dynamics
                              6.3.3.2. Target Disease Prevalence
                              6.3.3.3. Competitive Scenario
                              6.3.3.4. Regulatory Framework
                              6.3.3.5. UK Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.4. Germany
                              6.3.4.1. Key Country Dynamics
                              6.3.4.2. Target Disease Prevalence
                              6.3.4.3. Competitive Scenario
                              6.3.4.4. Regulatory Framework
                              6.3.4.5. Germany Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.5. France
                              6.3.5.1. Key Country Dynamics
                              6.3.5.2. Target Disease Prevalence
                              6.3.5.3. Competitive Scenario
                              6.3.5.4. Regulatory Framework
                              6.3.5.5. France Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.6. Italy
                              6.3.6.1. Key Country Dynamics
                              6.3.6.2. Target Disease Prevalence
                              6.3.6.3. Competitive Scenario
                              6.3.6.4. Regulatory Framework
                              6.3.6.5. Italy Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.7. Spain
                              6.3.7.1. Key Country Dynamics
                              6.3.7.2. Target Disease Prevalence
                              6.3.7.3. Competitive Scenario
                              6.3.7.4. Regulatory Framework
                              6.3.7.5. Spain Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.8. Denmark
                              6.3.8.1. Key Country Dynamics
                              6.3.8.2. Target Disease Prevalence
                              6.3.8.3. Competitive Scenario
                              6.3.8.4. Regulatory Framework
                              6.3.8.5. Denmark Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.9. Sweden
                              6.3.9.1. Key Country Dynamics
                              6.3.9.2. Target Disease Prevalence
                              6.3.9.3. Competitive Scenario
                              6.3.9.4. Regulatory Framework
                              6.3.9.5. Sweden Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.3.10. Norway
                              6.3.10.1.Key Country Dynamics
                              6.3.10.2.Target Disease Prevalence
                              6.3.10.3.Competitive Scenario
                              6.3.10.4.Regulatory Framework
                              6.3.10.5.Norway Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                      6.4. Asia Pacific
                          6.4.1. SWOT Analysis
                          6.4.2. Asia Pacific Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.3. Japan
                              6.4.3.1. Key Country Dynamics
                              6.4.3.2. Target Disease Prevalence
                              6.4.3.3. Competitive Scenario
                              6.4.3.4. Regulatory Framework
                              6.4.3.5. Japan Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.4. China
                              6.4.4.1. Key Country Dynamics
                              6.4.4.2. Target Disease Prevalence
                              6.4.4.3. Competitive Scenario
                              6.4.4.4. Regulatory Framework
                              6.4.4.5. China Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.5. India
                              6.4.5.1. Key Country Dynamics
                              6.4.5.2. Target Disease Prevalence
                              6.4.5.3. Competitive Scenario
                              6.4.5.4. Regulatory Framework
                              6.4.5.5. India Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.6. Australia
                              6.4.6.1. Key Country Dynamics
                              6.4.6.2. Target Disease Prevalence
                              6.4.6.3. Competitive Scenario
                              6.4.6.4. Regulatory Framework
                              6.4.6.5. Australia Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.7. Thailand
                              6.4.7.1. Key Country Dynamics
                              6.4.7.2. Target Disease Prevalence
                              6.4.7.3. Competitive Scenario
                              6.4.7.4. Regulatory Framework
                              6.4.7.5. Thailand Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.4.8. South Korea
                              6.4.8.1. Key Country Dynamics
                              6.4.8.2. Target Disease Prevalence
                              6.4.8.3. Competitive Scenario
                              6.4.8.4. Regulatory Framework
                              6.4.8.5. South Korea Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                      6.5. Latin America
                          6.5.1. SWOT Analysis
                          6.5.2. Latin America Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.5.3. Brazil
                              6.5.3.1. Key Country Dynamics
                              6.5.3.2. Target Disease Prevalence
                              6.5.3.3. Competitive Scenario
                              6.5.3.4. Regulatory Framework
                              6.5.3.5. Brazil Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.5.4. Mexico
                              6.5.4.1. Key Country Dynamics
                              6.5.4.2. Target Disease Prevalence
                              6.5.4.3. Competitive Scenario
                              6.5.4.4. Regulatory Framework
                              6.5.4.5. Mexico Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.5.5. Argentina
                              6.5.5.1. Key Country Dynamics
                              6.5.5.2. Target Disease Prevalence
                              6.5.5.3. Competitive Scenario
                              6.5.5.4. Regulatory Framework
                              6.5.5.5. Argentina Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                      6.6. MEA
                          6.6.1. SWOT Analysis
                          6.6.2. MEA Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.6.3. South Africa
                              6.6.3.1. Key Country Dynamics
                              6.6.3.2. Target Disease Prevalence
                              6.6.3.3. Competitive Scenario
                              6.6.3.4. Regulatory Framework
                              6.6.3.5. South Africa Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.6.4. Saudi Arabia
                              6.6.4.1. Key Country Dynamics
                              6.6.4.2. Target Disease Prevalence
                              6.6.4.3. Competitive Scenario
                              6.6.4.4. Regulatory Framework
                              6.6.4.5. Saudi Arabia Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.6.5. UAE
                              6.6.5.1. Key Country Dynamics
                              6.6.5.2. Target Disease Prevalence
                              6.6.5.3. Competitive Scenario
                              6.6.5.4. Regulatory Framework
                              6.6.5.5. UAE Sickle Cell Disease Market, 2018 - 2030 (USD Million)
                          6.6.6. Kuwait
                              6.6.6.1. Key Country Dynamics
                              6.6.6.2. Target Disease Prevalence
                              6.6.6.3. Competitive Scenario
                              6.6.6.4. Regulatory Framework
                              6.6.6.5. Kuwait Sickle Cell Disease Market, 2018 - 2030 (USD Million)
Chapter 7 Competitive Analysis
                  7.1 Company Categorization
                  7.2 Strategy Mapping
                      7.2.1 New product launch
                      7.2.2 Partnerships
                      7.2.3 Acquisition
                      7.2.4 Collaboration
                  7.3 Company Profiles
                      7.3.1 Novartis AG
                          7.3.1.1 Company overview
                          7.3.1.2 Financial performance
                          7.3.1.3 Product benchmarking
                          7.3.1.4 Strategic initiatives
                      7.3.2 Pfizer Inc.
                          7.3.2.1 Company overview
                          7.3.2.2 Financial performance
                          7.3.2.3 Product benchmarking
                          7.3.2.4 Strategic initiatives
                      7.3.3 bluebird bio, Inc.
                          7.3.3.1 Company overview
                          7.3.3.2 Financial performance
                          7.3.3.3 Product benchmarking
                          7.3.3.4 Strategic initiatives
                      7.3.4 GlycoMimetics
                          7.3.4.1 Company overview
                          7.3.4.2 Financial performance
                          7.3.4.3 Product benchmarking
                          7.3.4.4 Strategic initiatives
                      7.3.5 Emmaus Medical, Inc.
                          7.3.5.1 Company overview
                          7.3.5.2 Financial performance
                          7.3.5.3 Product benchmarking
                          7.3.5.4 Strategic initiatives
                      7.3.6 Bristol-Myers Squibb Company
                          7.3.6.1 Company overview
                          7.3.6.2 Financial performance
                          7.3.6.3 Product benchmarking
                          7.3.6.4 Strategic initiatives
                      7.3.7 CRISPR Therapeutics
                          7.3.7.1 Company overview
                          7.3.7.2 Financial performance
                          7.3.7.3 Product benchmarking
                          7.3.7.4 Strategic initiatives
                      7.3.8 Graphite Bio, Inc.
                          7.3.8.1 Company overview
                          7.3.8.2 Financial performance
                          7.3.8.3 Product benchmarking
                          7.3.8.4 Strategic initiatives

List of Tables

Table 1North America sickle cell disease treatment market, by country, 2018 - 2030 (USD Million)
Table 2 North America sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 3 North America Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 4 U.S. sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 5 U.S. Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 6 Canada sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 7 Canada Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 8 Europe sickle cell disease treatment market, by country, 2018 - 2030 (USD Million)
Table 9 Europe sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 10 Europe Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 11 UK sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 12 UK Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 13 Germany sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 14 Germany Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 15 France sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 16 France Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 17 Italy sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 18 Italy Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 19 Spain sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 20 Spain Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 21 Denmark sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 22 Denmark Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 23 Sweden sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 24 Sweden Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 25 Norway sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 26 Norway Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 27 Asia Pacific sickle cell disease treatment market, by country, 2018 - 2030 (USD Million)
Table 28 Asia Pacific sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 30 Japan sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 31 Japan Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 32 China sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 33 China Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 34 India sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 35 India Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 36 Australia sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 37 Australia Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 38 South Korea sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 39 South Korea Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 40 Thailand sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 41 Thailand Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 42 Latin America sickle cell disease treatment market, by country, 2018 - 2030 (USD Million)
Table 43 Latin America sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 44 Latin America Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 45 Brazil sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 46 Brazil Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 47 Mexico sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 48 Mexico Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 49 Argentina sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 50 Argentina Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 51 MEA sickle cell disease treatment market, by country, 2018 - 2030 (USD Million)
Table 52 MEA sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 53 MEA Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 54 South Africa sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 55 South Africa Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 58 UAE sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 59 UAE Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)
Table 60 Kuwait sickle cell disease treatment market, by treatment, 2018 - 2030 (USD Million)
Table 61 Kuwait Sickle Cell Disease Treatment Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain-based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market summary, 2023
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restrain relevance analysis (Current & future impact)
Fig. 10 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Sickle cell disease treatment market treatment outlook key takeaways
Fig. 13 Sickle cell disease treatment market: Treatment movement analysis
Fig. 14 Global bone marrow transplant market, 2018 - 2030 (USD Million)
Fig. 15 Global blood transfusion market, 2018 - 2030 (USD Million)
Fig. 16 Global pharmacotherapy market, 2018 - 2030 (USD Million)
Fig. 17 Sickle cell disease treatment market End-use outlook key takeaways
Fig. 18 Sickle cell disease treatment market: End-use movement analysis
Fig. 19 Global Hospitals market, 2018 - 2030 (USD Million)
Fig. 20 Global Specialty Clinics market, 2018 - 2030 (USD Million)
Fig. 21 Global other market, 2018 - 2030 (USD Million)
Fig. 22 Regional marketplace: Key takeaways
Fig. 23 Regional marketplace: Key takeaways
Fig. 24 North America sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Key country dynamics
Fig. 26 U.S. sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Key country dynamics
Fig. 28 Canada sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Key country dynamics
Fig. 31 UK sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 Germany sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 France sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 Spain sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Italy sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Denmark sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Sweden sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Norway sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Rest of Europe sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD, Million)
Fig. 47 Asia Pacific sickle cell disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Japan sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 China sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 India sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 South Korea sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Korea reimbursement scenario
Fig. 57 Key country dynamics
Fig. 58 Australia sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Thailand sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Rest of Asia Pacific sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Latin America sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Brazil sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Mexico sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Argentina sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Rest of Latin America sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 MEA sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 South Africa sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Saudi Arabia sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 UAE sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Kuwait sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Rest of MEA sickle cell disease treatment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key company categorization
Fig. 81 Company categorization
Fig. 82 Company market share analysis, 2023
Fig. 83 Strategic framework